CrossrefInfokarte
Can subcutaneous treprostinil be an alternative for treating pulmonary hypertension in patients with systemic sclerosis-related interstitial lung disease?
ARP Rheumatology · 2024
DOI: 10.63032/bbmb6759 ↗Abstract
Kein Abstract verfügbar.
EUVIMED